## Why Option 1 is correct Non-caseating granulomas (marked **B** in the submucosa) are present in approximately 30% of Crohn disease cases. When identified on biopsy, they are highly significant because they strongly support the diagnosis of Crohn disease and help exclude other granulomatous conditions such as tuberculosis (which shows caseating granulomas), sarcoidosis, and foreign body reactions. The absence of caseation is the key distinguishing feature—caseation favors TB, while non-caseating granulomas are characteristic of Crohn disease. This finding, combined with transmural inflammation and skip lesions, solidifies the diagnosis (Robbins 10e Ch 17; Harrison 21e Ch 326). ## Why each distractor is wrong - **Option 2**: Caseating granulomas are NOT seen in Crohn disease; they are characteristic of tuberculosis. Non-caseating granulomas are what define Crohn disease histologically. This reversal is a classic distractor. - **Option 3**: Non-caseating granulomas are present in only ~30% of Crohn disease cases, not >90%. Many patients with Crohn disease do not have granulomas on biopsy, yet the diagnosis is still made based on transmural inflammation, skip lesions, and clinical features. Granulomas are supportive but not required. - **Option 4**: The presence of granulomas alone does not indicate severity or mandate surgery. Granulomas are a histological marker of the disease process; clinical severity and complications (fistulas, strictures, perforation) determine management decisions. **High-Yield:** Non-caseating granulomas in Crohn disease (~30% sensitivity) are diagnostic when present but NOT required; absence does not exclude Crohn disease. Caseation = TB, not Crohn. [cite: Robbins 10e Ch 17; Harrison 21e Ch 326]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.